Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
about
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosisInhaled non-steroid anti-inflammatories for children and adults with bronchiectasisCurrent and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implicationsThe Evolution of Cystic Fibrosis CareEarly pulmonary inflammation and lung damage in children with cystic fibrosisMagnetoliposomes loaded with poly-unsaturated fatty acids as novel theranostic anti-inflammatory formulationsPhysiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential.The role of Lipoxin A4 in Cystic Fibrosis Lung Disease.Cystic Fibrosis: Microbiology and Host ResponseDigitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.Antimicrobial Activity of Ibuprofen Against Cystic Fibrosis Associated Gram-Negative Pathogens.Interval estimation of the overall treatment effect in a meta-analysis of a few small studies with zero events.Improvements in symptomatic treatment strategies for cystic fibrosis: delivering CF care in the 21st century
P2860
Q24185912-3DF7ABA6-1D9F-40AD-B851-7B3ED57B22F8Q24186378-295929A9-A4CE-4206-872F-9C1ABAAEB3BDQ26747065-694FB2F7-8F93-4F13-A7DF-E1716050FE50Q26999299-53DEA710-FA61-4B44-B1DB-32CD84221794Q27027040-6A71D04F-6E6B-4271-80BB-604BF7D611E4Q30909702-434882D1-C4C4-42BF-AF49-9CF67A81CAB2Q35250351-C23284C7-7DFD-4AAA-BF54-110E2290FED7Q37654922-7054A6AA-C111-4DB0-AFC1-07B04BFDCFB9Q38911644-30450366-6079-40D9-B244-EFA6D95E45E0Q40398640-A058966C-93D0-464A-A526-6C7CF34043DEQ43538692-C1E57087-FCA9-424F-B002-9A1AE8DC13A4Q50134125-5143B23B-0AEA-4D91-AE21-C50CF96D8587Q55078925-24C25F13-3A9E-405D-AAE7-375E675C113BQ57913519-C7CC00F5-BA7B-4B86-AF1F-3D24DE6BF967
P2860
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@ast
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@en
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@en-gb
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@nl
type
label
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@ast
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@en
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@en-gb
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@nl
prefLabel
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@ast
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@en
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@en-gb
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@nl
P2860
P1476
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
@en
P2093
Larry C Lands
Sanja Stanojevic
P2860
P356
10.1002/14651858.CD001505.PUB3
P577
2013-06-13T00:00:00Z